Background: Neurotoxicity of anaesthetics in developing brain cells is well documented in preclinical studies, yet results are conflicting in humans. The use of many and different outcome measures in human studies may contribute to this disagreement. Methods: We conducted a systematic review to identify all measures used to assess long-term neurocognitive outcomes following general anaesthesia (GA) and surgery in children. The quality of studies was assessed according to the Newcastle-Ottawa Scale (NOS) for observational studies. PubMed/MEDLINE, EMBASE, Cinahl, Web of Science, and the Cochrane Library were searched for studies investigating neurocognitive outcome after GA in children <18 yr. Results: Sixty-seven studies were identified from 19 countries during 1990e2017. Most assessments were performed within cognition, sensory-motor development, academic achievement or neuropsychological diagnosis. Few studies assessed other outcomes (magnetic resonance imaging, serum-biomarkers, mortality, neurological examination, measurement of head circumference, impairment of vision). Rating according to the NOS rewarded a mean of six stars out of nine. Some concerns prevail regarding potential inter-rater variability because of equivocal description of rating criteria. Specific features such as stability over lifetime and inter-relations of outcomes (e.g. prediction of subsequent development or diagnosis of neuropsychological conditions) are discussed. The importance of validity and reliability of the various test instruments are described. The studies vary immensely in important characteristics. Conclusions: Future observational studies should be more consistent in the choice of study population, age at exposure, follow-up, indication for and type of surgery, and outcomes. Assessment of sensory-motor development seems feasible in young children (age <4 yr), and intelligence/cognition in older children.
association between general anaesthesia (GA) in young children and subsequent impaired neurodevelopment remains to be properly established or rejected. Single and short exposures lasting <1 h are considered 'safe' regarding neurodevelopmental outcome. 1 In a recent sibling-matched cohort study it was reported that children exposed once for inguinal hernia repair before age 3 yr showed no difference in intelligence quotient testing compared with their unexposed siblings. 2 A Swedish population-based cohort study detected a low overall difference in academic achievement and intelligence after single and multiple exposures before age 4 yr for miscellaneous types of surgeries. 3 These findings concur with the results of an international randomised trial comparing neurodevelopmental outcome at age 2 yr between infants exposed to a brief sevoflurane anaesthesia or an awake spinal-/caudal anaesthetic for inguinal herniorrhaphy; no difference was found between groups. 4 Quite the opposite, some studies focusing on exposure in 3-or 4-yr-old children to anaesthesia for miscellaneous types of surgery indicate longterm effects on cognition, learning, and behavioural disorders. 5, 6 As an example, exposure to GA and surgery before age 3 yr was found to associate with a remarkably increased risk of being diagnosed with a developmental/behavioural disorder. 7 Interestingly, various authorities interpret the existing results differently. While European scientific societies agree, that at present, there is no human evidence to support any change in anaesthetic practice in children and pregnant women, 1 the Food and Drug Administration recently warned against anaesthesia in children <3 yr of age prolonged anaesthesia. 8 Such different interpretations might have serious clinical implications for patients (e.g. postponement of surgery).
The majority of studies within the field of anaesthesiarelated neurotoxicity are cohort studies, which knowingly are vulnerable to confounding. As a consequence, recent literature calls for the use of other modalities (e.g. neuroimaging and biomarkers), to evaluate neuro-apoptosis and neuro-inflammation. 9 Furthermore, other factors that might mitigate morbidity after GA and surgery in children are increasingly acknowledged and subjected to intensive research. 10e13 Despite this broadened search for answers, anaesthesia-related neurotoxicity has not yet been properly clinically defined. Consequently, it is unknown where clinical research should be focused. Multiple factors, for example, sample size; selection of exposed cohort; age at exposure; type of, and indication for, surgery; follow-up as well as type of outcome measures could likely influence results. We hypothesised that inconsistency in the choice of outcome measures, age at exposure, and differences in study quality are major confounding factors for divergent results obtained in human studies.
The aims of this systematic review were to identify the type of outcomes used in studies investigating neurodevelopmental consequences of anaesthesia/surgery exposure in infancy and early childhood. Further, we wished to compare the studies with regard to other crucial factors and assess the methodological quality of these studies.
Methods
The study protocol was published at PROSPERO (registration ID: CRD42016042450) and reported according to the PRISMA guidelines. 14 
Search strategy
We searched PubMed/MEDLINE, EMBASE, Cinahl, Web of Science and the Cochrane Library (last search on June 16, 2017) using relevant terms concerning 'general anaesthesia' and 'neurocognitive outcome'. Via the MESH database and the EMTREE thesaurus we identified relevant search terms. Additionally, the reference list of included studies was handchecked for other potentially relevant publications. 'Neurobehavioral outcome' was part of the search. However, most articles on postoperative behaviour assessed temporary changes (e.g. emergency delirium and anxiety). These were not considered to be long-term results of anaesthesia-related neurotoxicity and articles using only behaviour as outcomes were not included in the content analyses. Librarians at the Medical Research Library, part of The University Library of Southern Denmark, Odense University Hospital, Denmark approved the construction of the final search. The exact search for the respective databases is available as Supplementary Material (Supplementary 1).
Study selection
To be eligible for this review studies must report on:
Age at exposure <18 yr Exposure to single/multiple GA or surgery (it is assumed, that surgery is only delivered with a concomitant GA) Evaluation of cognitive function after the exposure(s) Studies must be published in peer reviewed journals, identified by experts within the field, or have been cited by peer reviewed papers.
We excluded studies that were not reported in English, evaluated neurotoxic effects of topically/locally administered anaesthetics, or studies conducted in animals.
Two authors (N.G.C. and S.K.) independently assessed title, abstract and full text for eligibility using the Covidence software (Covidence systematic review software, Veritas Health Innovation, Melbourne Australia. Available at https://www. covidence.org).
Outcomes
We identified all outcome measures used in studies investigating neurocognitive consequences of surgery and GA exposure in children (primary outcome).
Further, the quality of studies regarding selection and comparability of study participants, as well as ascertainment of outcomes were evaluated based on the Newcastle-Ottawa Scale (NOS). 15 
Data extraction
We recorded study ID, design, reason for anaesthesia (type of surgery or diagnostics), and specifics on anaesthetic procedure (type, drugs, doses, means of administration) if provided. We also recorded information on the population studied (study base, number of exposed/non-exposed individuals), age at exposure, male/female distribution, type of outcome, and age at assessment.
Quality assessment
Study quality was evaluated using the NOS for quality assessment of non-randomised studies. The evaluation comprised three broad perspectives: selection of study groups, comparability of groups, and ascertainment of either exposure or outcome of interest. The scale uses a 'star system'; each study can be accredited a maximum of nine stars if all requirements are met. Risk of bias evaluations of individual studies can be retrieved by contacting the corresponding author.
Results

Study selection
Our systematic literature review identified 18 011 titles after removal of duplicates. N.G.C. and S.K. independently screened titles and abstracts, eliminating irrelevant and double items. A total of 397 titles qualified for full text screening and finally, 67 studies were included in this review.
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The main reasons for excluding studies were:
'Wrong intervention': comparison of interventions other than or not related to anaesthesia 'Wrong outcomes': for example, emergency delirium shortly after procedure (i.e. within 30 days following exposure or temporary behavioural outcomes).
One article was excluded, because these results were based on re-analysis of a previously described dataset. 76 The process of selection is illustrated in Figure 1 .
Study outcomes
A variety of psychometric tests were used (Table 1) . For simplicity, tests were allocated to four core domains: intelligence/cognition, development, achievement, and screening/ diagnosis. In the majority of studies, more than one test was used, and often more than one domain was tested.
'Development' was assessed in 35 studies. One-third of these used the Bayley Scales of Infant Development (BSID) (2nd or 3rd edition) or parts hereof. Tests evaluating 'intelligence/ cognition' were used in 21 studies, with seven of these being the Wechsler Preschool and Primary Scale of Intelligence. In 15 studies assessing 'academics/achievement', this was either the sole measure or the primary outcome. The domain of 'diagnosis/screening', covering neuropsychological disorders and learning disability (LD), was used as an outcome measure in 14 studies. Magnetic resonance imaging (MRI) was performed in seven studies. Eight studies assessed miscellaneous outcomes including: biomarkers, mortality, neurological examination, measurement of head circumference or impairment of vision: visual acuity, refractive error, and thickness of retinal nerve fibre layer. The main features of included studies are summarised in Table 2 . Complete study characteristics (study identification, design, anaesthesia protocol, type of surgical/diagnostic procedure, cohort selection, number of exposed/non-exposed individuals, age at exposure, gender, age at follow-up, and outcome measures) are presented as Supplementary Material (Supplementary 2).
Overall, studies originated from 19 different countries published from 1990 to 2017. The annual publication rate has increased over time, ranging from one publication in 1990 to 15 in 2016. The prevalent study designs were retrospective and prospective observational studies. Number of exposed individuals ranged from n¼15 to n¼37 231 (mean n¼1454). In more than half of the studies (38 out of 67) the outcome was compared between exposed and unexposed individuals. Anaesthetic drugs and procedures were specified in 28 (42%) studies. Outcome was assessed at one point in time in 53 (79%) studies. Age at exposure and outcome assessment ranged from less than 30 days to age 20 yr, respectively (mean¼37 months). For the youngest infants, age at exposure seemed to cluster around 1e3 months (Fig. 2) . In many studies investigating outcome later than 2 yr of age, infants and toddlers were around 36e48 months old at time of exposure (Fig. 3) .
Quality assessment
Risk of bias evaluation according to NOS assessment tool for cohort studies is illustrated in Table 3 .
Overall, studies were rewarded three to eight stars (mean, six) out of a maximum of nine stars. As a result of a different design, one study was rewarded a 'low risk of bias' in three out of four domains according to the Cochrane risk of bias tool for randomised controlled trials. 4 Exposed individuals are representative of the particular community in 57 of the studies. According to the NOS manual, 'community' is defined as the study population (of exposed individuals). 15 Twenty-nine studies (43%) did not evaluate an outcome in non-exposed controls, which introduced selection bias.
If 'ascertainment of exposure' was based on a civil register, this was judged of equal quality as hospital files or journals, even though the data were collected for administrative purposes. 77 In total, 55 studies (82%) were labelled to have a low risk of bias in this category.
In less than half of the studies (n¼22) the relevant outcome was measured before exposure. This is not considered an As a result of the observational, prospective, or retrospective design of most studies internal validity could not easily be optimised during the design phase. Naturally, most studies adjust for potential confounding factors using stratification of relevant groups, propensity matching, or regression analysis.
A majority of studies detected outcome by independent assessment or linkage of (hospital) records. Only few blinded their assessors. As 29 (43%) studies did not include nonexposed controls, blinding would not have added any 
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Neurocognitive outcomes in children after general anaesthesia -1263 additional value and 'non-blinding' is not considered a significant risk of bias in these studies. Whether length to follow-up was adequate, was evaluated individually in each study depending on the outcome measure. For instance, in studies assessing academic achievement at age 15e16 yr following exposure before age 4 yr, this was considered 'adequate', based on the assumption that adolescents possess all cognitive skills necessary to sit a standardised test. Additionally, as the BSID is validated for young ages, assessment of infants using this scale was considered adequate. This domain was rewarded a 'low risk of bias' in 53 (79%) studies. In comparison, only 37 (55%) studies were rewarded a star for 'adequacy of follow-up'; either studies followed up on 70% or less of exposed individuals or did not provide a description of those lost.
Discussion
Numerous studies have investigated long-term cognitive consequences of GA, surgery, or both, in neonates and infants. Judged by the increasing numbers of papers published each year, the interest in this topic is growing, presumably because of the lack of a robust and reproducible phenotype. Investigators have used a variety of specific assessment tools, or parts hereof, to evaluate different criteria within development, cognition, intelligence, academic achievement, and neuropsychological diagnosis. Comparatively, few studies have assessed outcomes such as neuroimaging, 18 Age at exposure >2 yr of age (mean¼70 months). Table 3 Risk of bias evaluation; A-I represents rating categories according to Newcastla-Ottawa Scale for assessing quality of non-randomised studies. A, Representativeness of the exposed cohort; B, Selection of the non-exposed cohort; C, Ascertainment of exposure; D, Outcome of interest was not present at start of study; E, Comparability of cohorts -major factor controlled for; F, Comparability of cohorts -any additional factor controlled for; G, Assessment of outcome; H, Follow-up long enough for outcome to occur? I, Adequacy of follow-up of cohorts.
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Glatz and colleagues 78 So far, epidemiologic studies have shown contradictory results. Registerbased studies are unable to demonstrate any causative associations. Although this is largely made up for by the opportunity to analyse large sample sizes, epidemiologic studies have been criticised and the call for randomised clinical trials has been repetitively stated. Based on the findings in this review, this criticism may not be entirely reasonable, as age at exposure has not been assessed systematically. Rather, focus has been on infants or young children between 1 and 3 months or 2 and 4 yr, respectively. This clustering can probably be explained by the assumption that development of the infant brain is most vulnerable to potential toxins during peak synaptogenesis of neurons (i.e. period from 3rd trimester to 12e24 months of age). 79 In comparison, the effect of GA exposure during age 3 months to 2 yr or >4 yr has been investigated scarcely. As brain development in young children is dynamic and on-going, associations in other domains might have been missed. Furthermore, it may be reasonable to assume, that infants undergoing surgery in the first months of life suffer from significant underlying conditions, which might confound the effect of exposure to GA on cognitive outcome. The studies seem to resemble each other regarding design (i.e. retrospective cohorts), but vary immensely in all other characteristics highlighted in this review (type of, and indication for, surgery; sample size; age at exposure and follow-up; as well as outcome measures).
Cognition and neurodevelopment
Intelligence, covering several cognitive domains (memory, reasoning, spatial ability, executive function, and processing speed), is considered a relatively stable and constant trait throughout life. 80 Cognition in male adolescents was tested in the Vietnam Experience Study, a cohort of soldiers involved in military service abroad, 81 and these individuals were reassessed at middle-age. A high correlation between scores in young-and middle-aged individuals was found. In a Scottish birth cohort, intelligence was assessed in 11-yr-old children who were followed-up 66 yr later. It was concluded that mental abilities are stable across a human lifespan unless a person suffers severe diseases. 80 Similar findings have been confirmed in a multitude of similar longitudinal studies regarding intelligence. Assessment of development has focused on the domains of language, perception, and motor development. It has long been recognised that infant neuro-behaviour follows an age specific pattern. In 1931, Gesell 82 described the 'Developmental morphology of infant behaviour pattern' as 'significant consistencies in the tempo, the forms and sequences of behaviour growth which point to the presence of a lawful developmental mechanic'. Unlike intelligence, abilities within these domains change over time. Development within the norm is evaluated based on whether the child reaches predefined 'milestones'. Deviations from or delay in progression might be as a result of underlying disease or external factors. 83 Interestingly, development and overall cognitive ability has been shown to correlate. In a 34-yr follow-up of a sample of 307 children identified in the Copenhagen Perinatal Cohort comprising 9125 deliveries from late 1959 to 1961, an association between several milestones of motor development and intelligence in adulthood was demonstrated. 84 In a
French mother-child cohort, it was shown that milestones before age 2 yr predicted intelligence in 5e6-yr-old children. 85 In summary, sensorimotor development relates well to cognition/intelligence and psychiatric disorders. Further, as milestones are well defined, development can be assessed even in the youngest ages. At the same time, development can be influenced both positively and negatively by external factors (e.g. by interaction or with parents or severe diseases necessitating frequent treatment or hospitalisation, xenobiotics, etc.), which compromises the stability of development as an outcome measure.
Intelligence is a stable factor across lifetime, but assessment is not feasible until the child has achieved some basic cognitive skills. Hence, assessing children younger than school age is not recommended.
Neuropsychological diagnosis
LD, autism spectrum disorders (ASD), and attention deficit hyperactivity disorder (ADHD) have also been used as outcome measures in the current context. LD comprises dyscalculia and dyslexia. Both disorders are common (with prevalence~5% for each item). Their origin is multifactorial, and their clinical presentation heterogeneous and changing over time. 86, 87 LD has been associated with psychiatric diseases and maladaptive traits. 88 However, if LD is diagnosed and supportive interventions appointed, deficits can be attenuated. Additionally, differences in scores of verbal intelligence and performance intelligence have been shown to predict LD. 89 Importantly, a diagnosis of LD is not necessarily equivalent to lower intelligence scores. ASD is characterised by impaired neurodevelopment and considered to be a lifelong condition. 90, 91 Children with ASD have difficulties interacting and communicating socially and present a behavioural pattern shaped by strict routine. 81 Severity of symptoms varies among individuals and with development, 92 which aggravates the clinical diagnosis.
However, the course of sensorineural development relates to the clinical presentation and hence predicts the seriousness of the condition. 93 ADHD is a mental development disorder clinically presented by hyperactivity and impaired ability to focus and concentrate. ADHD has been linked with neurocognitive development. 94 While the natural course of ADHD cannot be predicted by neurocognitive assessments, the causal pathway of the disorder is known to consist of multiple factors, including an inherited genetic disposition. 95 The prevalence varies with gender, ethnicity, countries, states 96 and there prevails some disagreement whether ADHD should be diagnosed by detection of core symptoms only or whether emotional and executive functions should be assessed as well. 97 Several studies have used academic achievement (i.e. scores in standardised exams). Not surprising, intelligence and academic achievement are linked together. 98, 99 However, academic performance is influenced by many other factors unrelated to GA/surgical exposure, 25 for example, altered relationships with peers at school and low self-esteem because of childhood obesity, 100 as well as specific life-style factors (longer sleep duration 101 and physical activity 102 ). In a recent study by our group, achievement at the Danish national 9th grade exam was compared between 558 children undergoing surgery for isolated oral clefts and randomly selected controls. The type of oral cleft, parental age, and length of education were more important than number and timing of exposures. 75 
Miscellaneous outcomes
Neuroimaging by MRI offers measurement of gross brain structures. MRI has shown promising results in the early (<2 yr of age) identification of ASD. Children who were diagnosed with ASD later in life presented an atypical pattern of connectivity of brain regions compared with non-exposed children; microstructural properties of white matter fibre tracts were characterised by fractional anisotropy and axial diffusivity. Further, children with high risk of ASD presented blunted trajectories consistent with reduced fractional anisotropy. 103 Among studies identified in this review, few have used MRI to look for changes after exposure to GA in childhood. 35, 40, 63 As was shown, GA itself could not be associated with any reduction in brain tissue, exposed children had lower scores of performance and language intelligence, and lower scores were associated with decreased volume of grey matter in posterior brain regions. 40 However, 53 of 81 types of surgery were ear, nose, throat (ENT) related procedures. This (particular) population of children has been suspected to suffer language and speech problems and achieve poor academic results because of prolonged hearing loss caused by, for example, otitis media. 104, 105 One study compared MRI scans of premature infants (born <30 weeks of gestation) and neonates with low birth weight (<1250 g), both groups either exposed or non-exposed to GA and surgery at 39e42 weeks corrected age. Additionally, development was assessed at age 2 yr. Brain volume was decreased and mental developmental index score (one of many items included in the BSID III) lowered in exposed children. 35 As these results were based on 15 exposed and nonexposed individuals, they suffer from a comparatively small sample size.
The serum-concentration of S100B following GA was assessed as a secondary outcome in one study. 42 In traumatology, S100B was introduced as a marker of severity of brain damage after traumatic brain injury. 106, 107 It has also been used for follow-up of patients with malignant melanoma. 108 However, S100B is not brain-tissue specific 109, 110 and its utility as a marker for potential neuronal damage following GA is unknown.
Methodological considerations
Psychometric tests are used for commercial, research, and clinical purposes. 111 Crucial for evaluating the quality of a test are reliability (consistency of measurements of a test) and validity (degree to which a test measures, what it claims to measure). Internal reliability reflects the interrelation between items contained in a test.
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Validity is a crucial feature of a test. 113 Validity does not apply to the test itself but resembles a property of a test score. When a test has been 'validated' (i.e. from one language or country to another), its ability to measure the construct of interest (intelligence, behaviour, etc.) has been correlated with tests of the same construct ('convergent validity') or has shown poor correlation with a test of a different construct ('discriminative validity'). Validity is not a static factor but must be considered in each specific study context (study population, test users, overall setting). For instance, concurrent validity of the Bayley Developmental Index and the Cognitive Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/ CLAMS) was determined in a primary care health setting assessing children 12-and 30-months-old without suspected developmental delay. 113 The authors concluded that the CAT/CLAMS had reasonable concurrent validity with the Bayley Scales and was easy and time efficient to use by professionals (e.g. paediatricians) without special training. 114, 115 As shown in our data, sample sizes vary tremendously, with the lowest numbers being 15 35 and 21. 23,36,41,55 Small sample sizes are problematic, as they reduce the power of a study. This eventually reduces reliability of findings because of low probability of finding the true effects, reduced positive predictive value (i.e. the probability of a true association in case of a significant result) and 'effect inflation'. 116, 117 Considering the great number of children exposed to surgery and GA each year worldwide, the effect size of potential neurotoxicity is most likely to be minimal, as the clinical presentation or potential phenotype has not yet been defined. Evaluation of study effect size is not within the scope of this review. Nevertheless, reduced power because of small sample and effect size remains a major concern within the field of anaesthesia-related neurotoxicity research. Few studies (n¼22) have reported on 'baseline' values before exposure, that is, demonstrated that the outcome of interest (reduced intelligence, delay of development, etc.) was not present before exposure (Table 3) . However, inclusion of individuals prone to neurodevelopmental delay might lead to overestimation of an adverse effect of GA/surgery on neurocognitive outcome. Several studies have evaluated a selected study group knowingly associated with impaired neurodevelopment. 118, 119 These comprised children with hypoplastic left heart syndrome undergoing the Norwood procedure, 28 congenital diaphragmatic hernia, or gastroschisis. 51, 60 Children undergoing major surgery might suffer from other underlying diseases/conditions, which confound the effect estimate and blur a 'true' association.
Confounding by indication and selection bias is a concern in 29 (43%) studies, which did not compare outcome between exposed and non-exposed controls.
Similarly, the potential confounding by co-morbidity cannot be entangled in studies assessing outcome after exposure for miscellaneous types of surgery [n¼45 (67%)]: minor surgery, for instance laser surgery for vascular malformations 20 or inguinal hernia repair, 7,64 compared with major surgery, is less likely to associate with severe underlying disease. Some outcomes either vary with age (behaviour, development) or show a heterogenic clinical presentation (ASD, LD, ADHD). Detecting an impaired score within these 'unstable' domains might overestimate an effect size that the child might 'catch up' later.
'Loss-to-follow-up' or missing details of those lost are a concern in 29 (43%) studiesdwhether this loss underestimates or overestimates the true effect depends on the reason(s) why individuals cannot be assessed. As these studies either followed-up on less than 70% of respective study populations or do not account for reasons and characteristics of those lost, specifics cannot be eluded. In concordance with our findings, previously published data reported a loss-to-follow-up because of migration of approximately 30%. Within the framework of observational studies based on birth cohorts, increasing mobility was considered to represent a major challenge. However, the authors did not consider differences between migrants and non-migrant (i.e. prevalence of congenital defects, maternal age and level of education, compliance to attend prenatal visits, ethnicity or single parent status) to influence their results on the prevalence on LD in their specific cohort. 120 This may be a significantly flawed approach.
Quality assessment using the NOS
We chose (to use) the NOS for quality assessment of the included studies, as this scale has been recommended for cohort studies and endorsed by the Cochrane collaboration. 121 Evaluator burden has been described as less compared with other tools because of ease of use and limited time-consumption. 122 These findings do not coincide completely with our experience. Some decision rules for quality rating of domains are less comprehensive and prone to misinterpretations.
Evaluating (e.g. 'comparability') turned out to be difficult. Neurodevelopment in children is recognised as a complex and multifactorial phenomenon. Focusing on a single most important factor is frequently not possible. In studies evaluating academic achievements, 'male gender' was a major confounder, as boys perform poorer than girls. When studies investigated outcome after neonatal cardio-thoracic surgery, 'underlying conditions' also constituted a major confounder; the prognosis differed depending on the specific cardiac malformation necessitating surgery (for instance uni-ventricular vs bi-ventricular cardiac malformation). We followed the same rule of decision-making for studies investigating outcomes after miscellaneous surgeries, as the impact of underlying condition is assumed to be pivotal for development. Recently, 13 papers were reviewed and rated according to NOS as part of a meta-analysis, discussing outcome measurements after a single GA administered before 3 and 4 yr. 123 All 13 papers were included in the current study. The overall number of stars rewarded varied slightly from ours. Because subgroup labelling is not stated, any variation in decision-making cannot be specifically compared. Based on these considerations, we agree that inter-rater reliability of the NOS is a concern.
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To the best of our knowledge, we identified all studies relevant to this review according to inclusion criteria. As a result of exclusion of papers not published in English, we might have missed relevant work.
Conclusion
It is very likely that early exposure to general anaesthesia in young children affects development in some neurocognitive domains more than others. 125 The effect(s) of GA (and surgery) in young children have been assessed by various outcome measures. This variability in test items used reflects the problem that the clinical presentation of a potential damaging impact on young children's brains following GA/ surgery is not properly defined. Studies within this topic continue to be inconsistent regarding outcome measures as well as other important factors. Consequently, future observational studies are only considered meaningful if they are conducted in cohorts of considerable sample size and comparable regarding type of surgery, comorbidity, age at exposure, follow-up, indication for intervention, and outcome. As development of neurocognition is multifactorial, the investigation of a single causative factor might be too simplistic. Neurotoxicity of anaesthetics might be clinically detectable only if several factors occur in combination.
Regarding the choice of outcome measurement, the prevailing use of development tests is considered feasible in infants. In older age groups (i.e. >6 yr), intelligence tests seem reasonable, because intelligence is a stable characteristic and covers cognitive functions, as do academic achievements.
The majority of studies included in this review have a low to moderate risk of bias in the domains of selection, comparability, and outcome assessment. However, some concerns exist about the feasibility of NOS. To avoid confusion, it is recommended to specify quality-rating rules. 
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